358 related articles for article (PubMed ID: 24019252)
21. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells.
Yuan SH; Martin J; Elia J; Flippin J; Paramban RI; Hefferan MP; Vidal JG; Mu Y; Killian RL; Israel MA; Emre N; Marsala S; Marsala M; Gage FH; Goldstein LS; Carson CT
PLoS One; 2011 Mar; 6(3):e17540. PubMed ID: 21407814
[TBL] [Abstract][Full Text] [Related]
22. Neurotrophin-3 gene-modified Schwann cells promote TrkC gene-modified mesenchymal stem cells to differentiate into neuron-like cells in poly(lactic-acid-co-glycolic acid) multiple-channel conduit.
Zhang YQ; He LM; Xing B; Zeng X; Zeng CG; Zhang W; Quan DP; Zeng YS
Cells Tissues Organs; 2012; 195(4):313-22. PubMed ID: 21828999
[TBL] [Abstract][Full Text] [Related]
23. Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models.
Peng J; Liu Q; Rao MS; Zeng X
J Biomol Screen; 2013 Jun; 18(5):522-33. PubMed ID: 23364514
[TBL] [Abstract][Full Text] [Related]
24. A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs).
Varun D; Srinivasan GR; Tsai YH; Kim HJ; Cutts J; Petty F; Merkley R; Stephanopoulos N; Dolezalova D; Marsala M; Brafman DA
Acta Biomater; 2017 Jan; 48():120-130. PubMed ID: 27989923
[TBL] [Abstract][Full Text] [Related]
25. Using Human Neural Progenitor Cell Models to Conduct Large-Scale Drug Screens for Neurological and Psychiatric Diseases.
Hunt JFVS; Li M; Zhao X; Bhattacharyya A
Methods Mol Biol; 2019; 1942():79-88. PubMed ID: 30900177
[TBL] [Abstract][Full Text] [Related]
26. Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture.
Odawara A; Saitoh Y; Alhebshi AH; Gotoh M; Suzuki I
Biochem Biophys Res Commun; 2014 Jan; 443(4):1176-81. PubMed ID: 24406164
[TBL] [Abstract][Full Text] [Related]
27. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult.
Ellis P; Fagan BM; Magness ST; Hutton S; Taranova O; Hayashi S; McMahon A; Rao M; Pevny L
Dev Neurosci; 2004; 26(2-4):148-65. PubMed ID: 15711057
[TBL] [Abstract][Full Text] [Related]
28. Functional Comparison of Neuronal Cells Differentiated from Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Different Oxygen and Medium Conditions.
Yamazaki K; Fukushima K; Sugawara M; Tabata Y; Imaizumi Y; Ishihara Y; Ito M; Tsukahara K; Kohyama J; Okano H
J Biomol Screen; 2016 Dec; 21(10):1054-1064. PubMed ID: 28139961
[TBL] [Abstract][Full Text] [Related]
29. hVGAT-mCherry: A novel molecular tool for analysis of GABAergic neurons derived from human pluripotent stem cells.
DeRosa BA; Belle KC; Thomas BJ; Cukier HN; Pericak-Vance MA; Vance JM; Dykxhoorn DM
Mol Cell Neurosci; 2015 Sep; 68():244-57. PubMed ID: 26284979
[TBL] [Abstract][Full Text] [Related]
30. In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol.
Ozolek JA; Jane EP; Esplen JE; Petrosko P; Wehn AK; Erb TM; Mucko SE; Cote LC; Sammak PJ
Methods Mol Biol; 2010; 584():71-95. PubMed ID: 19907972
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric High Content Analysis for assessment of neurotoxicity in differentiated neuronal cell lines and human embryonic stem cell-derived neurons.
Wilson MS; Graham JR; Ball AJ
Neurotoxicology; 2014 May; 42():33-48. PubMed ID: 24705302
[TBL] [Abstract][Full Text] [Related]
32. Analysing human neural stem cell ontogeny by consecutive isolation of Notch active neural progenitors.
Edri R; Yaffe Y; Ziller MJ; Mutukula N; Volkman R; David E; Jacob-Hirsch J; Malcov H; Levy C; Rechavi G; Gat-Viks I; Meissner A; Elkabetz Y
Nat Commun; 2015 Mar; 6():6500. PubMed ID: 25799239
[TBL] [Abstract][Full Text] [Related]
33. Labeling pluripotent stem cell-derived neural progenitors with iron oxide particles for magnetic resonance imaging.
Sart S; Bejarano FC; Yan Y; Grant SC; Li Y
Methods Mol Biol; 2015; 1283():43-52. PubMed ID: 25304204
[TBL] [Abstract][Full Text] [Related]
34. Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes.
Ishii MN; Yamamoto K; Shoji M; Asami A; Kawamata Y
Toxicology; 2017 Aug; 389():130-138. PubMed ID: 28666936
[TBL] [Abstract][Full Text] [Related]
35. Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons.
Rehbach K; Kesavan J; Hauser S; Ritzenhofen S; Jungverdorben J; Schüle R; Schöls L; Peitz M; Brüstle O
Sci Rep; 2019 Jul; 9(1):9615. PubMed ID: 31270336
[TBL] [Abstract][Full Text] [Related]
36. High content screening for modulators of cardiac differentiation in human pluripotent stem cells.
Spiering S; Davidovics H; Bushway PJ; Mercola M; Willems E
Methods Mol Biol; 2015; 1263():43-61. PubMed ID: 25618335
[TBL] [Abstract][Full Text] [Related]
37. Derivation, propagation, and characterization of neuroprogenitors from pluripotent stem cells (hESCs and hiPSCs).
Lie KH; Chung HC; Sidhu KS
Methods Mol Biol; 2012; 873():237-46. PubMed ID: 22528359
[TBL] [Abstract][Full Text] [Related]
38. Recombinant spider silk matrices for neural stem cell cultures.
Lewicka M; Hermanson O; Rising AU
Biomaterials; 2012 Nov; 33(31):7712-7. PubMed ID: 22863380
[TBL] [Abstract][Full Text] [Related]
39. hiPS Cell-Derived Neurons for High-Throughput Screening.
Traub S; Heilker R
Methods Mol Biol; 2019; 1994():243-263. PubMed ID: 31124122
[TBL] [Abstract][Full Text] [Related]
40. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
Wang C; Ward ME; Chen R; Liu K; Tracy TE; Chen X; Xie M; Sohn PD; Ludwig C; Meyer-Franke A; Karch CM; Ding S; Gan L
Stem Cell Reports; 2017 Oct; 9(4):1221-1233. PubMed ID: 28966121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
